Sentry BioPharma Services ApS — Credit Rating and Financial Key Figures
CVR number: 41330619
Nybrogade 12, 1203 København K
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Other operating income | 542.71 | 2 064.88 | |||
| External services | - 381.56 | - 492.64 | -1 574.09 | -1 608.13 | -1 668.63 |
| Rents | - 325.41 | - 481.97 | |||
| Gross profit | - 381.56 | - 492.64 | -1 574.09 | -1 065.42 | 396.25 |
| Wages and salaries | - 421.79 | - 485.69 | |||
| Other operating expenses | - 275.89 | -6.89 | -20.88 | -26.83 | |
| Total depreciation | -7.71 | ||||
| EBIT | - 381.56 | - 776.25 | -3 005.78 | -3 796.64 | -2 405.76 |
| Other financial income | 22.92 | 16.46 | 576.57 | 484.87 | 62.88 |
| Other financial expenses | -3.63 | - 296.04 | -92.42 | - 493.62 | - 696.90 |
| Pre-tax profit | - 362.27 | -1 055.83 | -2 821.35 | -3 614.91 | -3 275.52 |
| Net earnings | - 362.27 | -1 055.83 | -2 821.35 | -3 614.91 | -3 275.52 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Development expenditure | 696.85 | ||||
| Intangible assets total | 696.85 | ||||
| Buildings | 499.98 | ||||
| Machinery and equipment | 2 686.29 | 2 912.41 | 2 628.19 | 2 497.22 | 2 137.82 |
| Tangible assets total | 2 686.29 | 2 912.41 | 2 628.19 | 2 497.22 | 2 637.80 |
| Other non-current investments | 0.00 | - 840.02 | 0.00 | ||
| Investments total | 0.00 | - 840.02 | 0.00 | ||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 620.20 | 673.73 | |||
| Prepayments and accrued income | 96.93 | 50.78 | 92.36 | ||
| Current other receivables | 55.68 | 50.05 | |||
| Current deferred tax assets | 189.23 | 872.78 | |||
| Short term receivables total | 96.93 | 915.89 | 1 688.91 | ||
| Cash and bank deposits | 36.37 | 166.64 | 113.06 | 349.75 | 320.65 |
| Cash and cash equivalents | 36.37 | 166.64 | 113.06 | 349.75 | 320.65 |
| Balance sheet total (assets) | 2 722.66 | 3 079.05 | 2 695.01 | 3 762.86 | 4 647.36 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 |
| Other reserves | 0.00 | ||||
| Retained earnings | - 362.27 | -1 418.11 | -4 239.46 | -7 854.37 | |
| Profit of the financial year | - 362.27 | -1 055.83 | -2 821.35 | -3 614.91 | -3 275.52 |
| Shareholders equity total | - 322.27 | -1 378.10 | -4 199.46 | -7 814.37 | -11 089.89 |
| Non-current liabilities total | |||||
| Current trade creditors | 157.37 | 191.34 | 455.37 | 1 041.39 | |
| Current owed to group member | 3 044.93 | 4 299.78 | 6 640.30 | 10 606.40 | 13 460.42 |
| Short-term deferred tax liabilities | 27.10 | 21.93 | |||
| Other non-interest bearing current liabilities | 0.00 | 62.83 | 488.35 | 1 213.51 | |
| Current liabilities total | 3 044.93 | 4 457.15 | 6 894.47 | 11 577.23 | 15 737.25 |
| Balance sheet total (liabilities) | 2 722.66 | 3 079.05 | 2 695.01 | 3 762.86 | 4 647.36 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.